Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
- PMID: 19337252
- PMCID: PMC2676558
- DOI: 10.1038/sj.bjc.6605011
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
Abstract
Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against ovarian endometriotic cysts is only superficially known. We, thus, analysed serum HE4 concentrations together with a tumour marker CA125 in serum samples of women diagnosed with various types of endometriosis, endometrial cancer or ovarian cancer, and in samples from healthy controls. The mean serum concentration of HE4 was significantly higher in serum samples of patients with both endometrial (99.2 pM, P<0.001) and ovarian (1125.4 pM, P<0.001) cancer but not with ovarian endometriomas (46.0 pM) or other types of endometriosis (45.5 pM) as compared with healthy controls (40.5 pM). The serum CA125 concentrations were elevated in patients with ovarian cancer, advanced endometriosis with peritoneal or deep lesions, or ovarian endometriomas, but not in the patients with endometrial cancer. The microarray results revealed that the mRNA expression of the genes encoding HE4 and CA125 reflected the serum protein concentrations. Taken together, measuring both HE4 and CA125 serum concentrations increases the accuracy of ovarian cancer diagnosis and provides valuable information to discriminate ovarian tumours from ovarian endometriotic cysts.
Figures
Comment in
-
Usefulness of serum HE4 in endometriotic cysts.Br J Cancer. 2009 Aug 4;101(3):548. doi: 10.1038/sj.bjc.6605119. Epub 2009 Jun 9. Br J Cancer. 2009. PMID: 19513069 Free PMC article. No abstract available.
References
-
- (1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67: 817–821 - PubMed
-
- Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers, FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209–262 - PubMed
-
- Drapkin R, von Horsten H, Lin Y, Mok S, Crum C, Welch W, Hecht J (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65: 2162–2169 - PubMed
-
- Gagnon A, Ye B (2008) Discovery and application of protein biomarkers for ovarian cancer. Curr Opin Obstet Gynecol 20: 9–13 - PubMed
-
- Galgano M, Hampton G, Frierson HJ (2006) Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 19: 847–853 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
